Sfoglia per Afferenza Dipartimento di Scienze cliniche applicate e biotecnologiche
Tamsulosin improves clearance of renal stones larger than 10mm after eswl
2006-01-01 Gravina, GIOVANNI LUCA; Costa, Am; Ronchi, P; PARADISO GALATIOTO, Giuseppe; Pace, G; Gualà, L; Martella, O; Simoncini, G; Ranieri, G; Angelozzi, G; Coscione, M; Vicentini, Carlo
Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones
2005-01-01 Gravina, GIOVANNI LUCA; Costa, Am; Ronchi, P; Galatioto, Gp; Angelucci, Adriano; Castellani, D; Narcisi, F; Vicentini, Carlo
TAMSULOSINA E TADALAFIL IN PAZIENTI CON IPERTROFIA PROSTATICA BENIGNA E DISFUNZIONE ERETTILE: NOSTRA ESPERIENZA CON LA TERAPIA COMBINATA A LUNGO TERMINE
2006-01-01 P., Ronchi; PARADISO GALATIOTO, Giuseppe; Gravina, GIOVANNI LUCA; A. M., Costa; G., Pace; Vicentini, Carlo
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain
2014-01-01 Mercadante, Sebastiano; Porzio, Giampiero; Adile, Claudio; Aielli, Federica; Cortegiani, Andrea; Dickenson, Anthony; Casuccio, Alessandra
Tapentadol in cancer pain management: a prospective open-label study
2012-01-01 Mercadante, S; Porzio, Giampiero; Ferrera, P; Aielli, Federica; Adile, C; Ficorella, Corrado; Giarratano, A; Casuccio, A.
target disruption of TGFbeta/Smad3 signaling confers resistance to intestinal fibrosis in the mouse
2006-01-01 Sferra, Roberta; Vetuschi, Antonella; Continenza, Maria Adelaide; Latella, Giovanni; Zanninelli, G; D'Angelo, V; Catitti, V; Onori, P.
Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice
2009-01-01 Latella, Giovanni; Vetuschi, Antonella; Sferra, Roberta; Catitti, V; D'Angelo, A; Zanninelli, G; Flanders, Kc; Gaudio, E.
Targeted disruption of TGF-beta/Smad3 signalling confers resistance to intestinal fibrosis.
2006-01-01 Latella, Giovanni; Zanninelli, G; Vetuschi, Antonella; Sferra, Roberta; D’Angelo, A; Catitti, V; Chiaramente, M; Caprilli, R; Gaudio, E.
Targeted disruption of TGF-beta/Smad3 signalling confers resistance to intestinal fibrosis.
2006-01-01 Latella, Giovanni; Zanninelli, G; Vetuschi, Antonella; Sferra, Roberta; D’Angelo, A; Catitti, V; Chiaramonte, M; Gaudio, E; Caprilli, R.
Targeted disruption of TGF-/Smad3 signalling confers resistance to intestinal fibrosis.
2006-01-01 Latella, Giovanni; Zanninelli, G; Vetuschi, Antonella; Sferra, Roberta; D’Angelo, A; Catitti, V; Frieri, G; Gaudio, E; Caprilli, R.
Targeted Lipidomics Investigation of N-acylethanolamines in a Transgenic Mouse Model of AD: A Longitudinal Study
2019-01-01 Piscitelli, F; Coccurello, R; Totaro, A; Leuti, A; Giacovazzo, G; Verde, R; Rossi, E; Vulpiani, Mp; Ferri, N; Stuffier, Rg; Di Marzo, V; Oddi, S; Bisogno, T; Maccarrone, M
Targeted synthetic pharmacotherapy for psoriatic arthritis: state of the art
2020-01-01 Caso, F.; Navarini, L.; Ruscitti, P.; Chimenti, M. S.; Girolimetto, N.; Del Puente, A.; Giacomelli, R.; Scarpa, R.; Costa, L.
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives
2020-01-01 De Matteis, E.; Guglielmetti, M.; Ornello, R.; Spuntarelli, V.; Martelletti, P.; Sacco, S.
Targeting costimulatory molecules to improve antitumor immunity.
2012-01-01 Capece, D; Verzella, Daniela; Fischietti, Mariafausta; Zazzeroni, Francesca; Alesse, Edoardo
Targeting ddx3x helicase activity with ba103 shows promising therapeutic effects in preclinical glioblastoma models
2021-01-01 Brai, A.; Riva, V.; Clementi, L.; Falsitta, L.; Zamperini, C.; Sinigiani, V.; Festuccia, C.; Sabetta, S.; Aiello, D.; Roselli, C.; Garbelli, A.; Trivisani, C. I.; Maccari, L.; Bugli, F.; Sanguinetti, M.; Calandro, P.; Chiariello, M.; Quaranta, P.; Botta, L.; Angelucci, A.; Maga, G.; Botta, M.
Targeting ERBB receptors to inhibit metastasis: old hopes and new certainties
2009-01-01 Angelucci, Adriano
Targeting hypoxic response for cancer therapy
2016-01-01 Paolicchi, E.; Gemignani, F.; Krstic-Demonacos, M.; Dedhar, S.; Mutti, L.; Landi, S.
Targeting MMP-2, MMP-9 and MMP-13 in pancreatic juice
2013-01-01 Sulpizio, Sara; Franceschini, Nicola; Ianni, Andrea; Locatelli, Marcello; Carlucci, Giuseppe; Bassi, C; Cotellese, Roberto; Innocenti, Paolo; Selvaggi, Federico
Targeting neuroprotection clinical trials to ischemic stroke patients with potential to benefit from therapy
2004-01-01 Weir, C. J.; Kaste, M; Lees, K. R.; FOR THE, Glycine; ANTAGONIST IN NEUROPROTECTION GAIN, International; STEERING COMMITTEE AND, Investigators; Carolei, Antonio
Targeting PDE4 cAMP phosphodiesterases to control hepatocellular carcinoma growth
2016-01-01 Ragusa, Federica; Cardarelli, Silvia; Galli, Francesca; Giardi, MARIA FEDERICA; Carusi, Mariacarla; Cinque, Benedetta; Giorgi, Mauro; Massimi, Mara
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Tamsulosin improves clearance of renal stones larger than 10mm after eswl | 1-gen-2006 | Gravina, GIOVANNI LUCA; Costa, Am; Ronchi, P; PARADISO GALATIOTO, Giuseppe; Pace, G; Gualà, L; Martella, O; Simoncini, G; Ranieri, G; Angelozzi, G; Coscione, M; Vicentini, Carlo | |
Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones | 1-gen-2005 | Gravina, GIOVANNI LUCA; Costa, Am; Ronchi, P; Galatioto, Gp; Angelucci, Adriano; Castellani, D; Narcisi, F; Vicentini, Carlo | |
TAMSULOSINA E TADALAFIL IN PAZIENTI CON IPERTROFIA PROSTATICA BENIGNA E DISFUNZIONE ERETTILE: NOSTRA ESPERIENZA CON LA TERAPIA COMBINATA A LUNGO TERMINE | 1-gen-2006 | P., Ronchi; PARADISO GALATIOTO, Giuseppe; Gravina, GIOVANNI LUCA; A. M., Costa; G., Pace; Vicentini, Carlo | |
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain | 1-gen-2014 | Mercadante, Sebastiano; Porzio, Giampiero; Adile, Claudio; Aielli, Federica; Cortegiani, Andrea; Dickenson, Anthony; Casuccio, Alessandra | |
Tapentadol in cancer pain management: a prospective open-label study | 1-gen-2012 | Mercadante, S; Porzio, Giampiero; Ferrera, P; Aielli, Federica; Adile, C; Ficorella, Corrado; Giarratano, A; Casuccio, A. | |
target disruption of TGFbeta/Smad3 signaling confers resistance to intestinal fibrosis in the mouse | 1-gen-2006 | Sferra, Roberta; Vetuschi, Antonella; Continenza, Maria Adelaide; Latella, Giovanni; Zanninelli, G; D'Angelo, V; Catitti, V; Onori, P. | |
Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice | 1-gen-2009 | Latella, Giovanni; Vetuschi, Antonella; Sferra, Roberta; Catitti, V; D'Angelo, A; Zanninelli, G; Flanders, Kc; Gaudio, E. | |
Targeted disruption of TGF-beta/Smad3 signalling confers resistance to intestinal fibrosis. | 1-gen-2006 | Latella, Giovanni; Zanninelli, G; Vetuschi, Antonella; Sferra, Roberta; D’Angelo, A; Catitti, V; Chiaramente, M; Caprilli, R; Gaudio, E. | |
Targeted disruption of TGF-beta/Smad3 signalling confers resistance to intestinal fibrosis. | 1-gen-2006 | Latella, Giovanni; Zanninelli, G; Vetuschi, Antonella; Sferra, Roberta; D’Angelo, A; Catitti, V; Chiaramonte, M; Gaudio, E; Caprilli, R. | |
Targeted disruption of TGF-/Smad3 signalling confers resistance to intestinal fibrosis. | 1-gen-2006 | Latella, Giovanni; Zanninelli, G; Vetuschi, Antonella; Sferra, Roberta; D’Angelo, A; Catitti, V; Frieri, G; Gaudio, E; Caprilli, R. | |
Targeted Lipidomics Investigation of N-acylethanolamines in a Transgenic Mouse Model of AD: A Longitudinal Study | 1-gen-2019 | Piscitelli, F; Coccurello, R; Totaro, A; Leuti, A; Giacovazzo, G; Verde, R; Rossi, E; Vulpiani, Mp; Ferri, N; Stuffier, Rg; Di Marzo, V; Oddi, S; Bisogno, T; Maccarrone, M | |
Targeted synthetic pharmacotherapy for psoriatic arthritis: state of the art | 1-gen-2020 | Caso, F.; Navarini, L.; Ruscitti, P.; Chimenti, M. S.; Girolimetto, N.; Del Puente, A.; Giacomelli, R.; Scarpa, R.; Costa, L. | |
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives | 1-gen-2020 | De Matteis, E.; Guglielmetti, M.; Ornello, R.; Spuntarelli, V.; Martelletti, P.; Sacco, S. | |
Targeting costimulatory molecules to improve antitumor immunity. | 1-gen-2012 | Capece, D; Verzella, Daniela; Fischietti, Mariafausta; Zazzeroni, Francesca; Alesse, Edoardo | |
Targeting ddx3x helicase activity with ba103 shows promising therapeutic effects in preclinical glioblastoma models | 1-gen-2021 | Brai, A.; Riva, V.; Clementi, L.; Falsitta, L.; Zamperini, C.; Sinigiani, V.; Festuccia, C.; Sabetta, S.; Aiello, D.; Roselli, C.; Garbelli, A.; Trivisani, C. I.; Maccari, L.; Bugli, F.; Sanguinetti, M.; Calandro, P.; Chiariello, M.; Quaranta, P.; Botta, L.; Angelucci, A.; Maga, G.; Botta, M. | |
Targeting ERBB receptors to inhibit metastasis: old hopes and new certainties | 1-gen-2009 | Angelucci, Adriano | |
Targeting hypoxic response for cancer therapy | 1-gen-2016 | Paolicchi, E.; Gemignani, F.; Krstic-Demonacos, M.; Dedhar, S.; Mutti, L.; Landi, S. | |
Targeting MMP-2, MMP-9 and MMP-13 in pancreatic juice | 1-gen-2013 | Sulpizio, Sara; Franceschini, Nicola; Ianni, Andrea; Locatelli, Marcello; Carlucci, Giuseppe; Bassi, C; Cotellese, Roberto; Innocenti, Paolo; Selvaggi, Federico | |
Targeting neuroprotection clinical trials to ischemic stroke patients with potential to benefit from therapy | 1-gen-2004 | Weir, C. J.; Kaste, M; Lees, K. R.; FOR THE, Glycine; ANTAGONIST IN NEUROPROTECTION GAIN, International; STEERING COMMITTEE AND, Investigators; Carolei, Antonio | |
Targeting PDE4 cAMP phosphodiesterases to control hepatocellular carcinoma growth | 1-gen-2016 | Ragusa, Federica; Cardarelli, Silvia; Galli, Francesca; Giardi, MARIA FEDERICA; Carusi, Mariacarla; Cinque, Benedetta; Giorgi, Mauro; Massimi, Mara |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile